TXN and diabetes mellitus: In non-obese diabetic (NOD) mice (T1DM model) or streptozocin (STZ) induced T1DM model mice, β-cell-specific overexpression of Trx1 markedly reduces the incidence of diabetes without improving insulin secretory capacity, insulin content, or the development of insulitis compared with those of littermate controls (55).